The CEPI centralised laboratory network: supporting COVID-19 vaccine development.

Kumar, Arun; Bernasconi, Valentina; Manak, Mark; de Almeida Aranha, Ana Paula; Kristiansen, Paul A

Kumar, Arun; Bernasconi, Valentina; Manak, Mark; de Almeida Aranha, Ana Paula; Kristiansen, Paul A.

Kumar A; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway. Electronic address: arun.kumar@cepi.net.
Bernasconi V; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.
Manak M; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.
de Almeida Aranha AP; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.
Kristiansen PA; Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo 0473, Norway.

Lancet ; 397(10290): 2148-2149, 2021 06 05.

Article in English | MEDLINE | ID: covidwho-1253770

Subject(s)

COVID-19 Vaccines/supply & distribution; COVID-19/prevention & control; Immunogenicity, Vaccine; Internationality; Laboratories/standards; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Internationality / Immunogenicity, Vaccine / COVID-19 Vaccines / COVID-19 / Laboratories Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google